| |
| |
| Exchange: |
N/A |
| Security
Type: |
Common |
| Shares
Out: |
72,066,000 |
| Market
Cap: |
3.73(B) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$14.28 - $51.39 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Health Services |
| Level
III Sector: |
Medical Instruments & Supplies |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : 6.8 |
| Insider 3/6 Months : 7.4 |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Tandem Diabetes Care is a medical device company engaged in designing, developing and commercializing products for people with insulin-dependent diabetes. Co.'s manufacturing, sales and support activities focus on Co.'s pump platform, the t:slim X2 Insulin Delivery System (t:slim X2) and its complementary product offerings. Co.'s t:slim X2 hardware platform is the commercial insulin pump that allows users to update their pumps' software from a personal computer. In addition to insulin pumps, Co. sells disposable products that are used together with its pumps, including cartridges for storing and delivering insulin, and infusion sets that connect the insulin pump to a user's body.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
5,000 |
14,135 |
30,150 |
| Total Buy Value |
$0 |
$94,778 |
$241,507 |
$725,491 |
| Total People Bought |
0 |
1 |
4 |
5 |
| Total Buy Transactions |
0 |
1 |
4 |
7 |
| Total Shares Sold |
0 |
0 |
0 |
45,097 |
| Total Sell Value |
$0 |
$0 |
$0 |
$2,075,699 |
| Total People Sold |
0 |
0 |
0 |
1 |
| Total Sell Transactions |
0 |
0 |
0 |
4 |
| End Date |
2024-02-25 |
2023-11-24 |
2023-05-26 |
2022-05-26 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Gasser Elizabeth Anne |
EVP, Chief Strategy Officer |
• – – |
2022-05-27 |
4 |
D |
$70.81 |
$9,134 |
D/D |
(129) |
1,319 |
|
- |
|
| Gasser Elizabeth Anne |
EVP, Chief Strategy Officer |
• – – |
2022-05-27 |
4 |
OE |
$0.00 |
$0 |
D/D |
373 |
1,448 |
|
- |
|
| Sheridan John F |
PRESIDENT & CEO |
• • – |
2022-05-27 |
4 |
D |
$70.81 |
$28,820 |
D/D |
(407) |
12,375 |
|
- |
|
| Sheridan John F |
PRESIDENT & CEO |
• • – |
2022-05-27 |
4 |
OE |
$0.00 |
$0 |
D/D |
820 |
12,782 |
|
- |
|
| Leal James |
SVP, Operations |
• – – |
2022-05-27 |
4 |
D |
$70.81 |
$9,772 |
D/D |
(138) |
5,024 |
|
- |
|
| Leal James |
SVP, Operations |
• – – |
2022-05-27 |
4 |
OE |
$0.00 |
$0 |
D/D |
310 |
5,162 |
|
- |
|
| Vosseller Leigh |
EVP & CHIEF FINANCIAL OFFICER |
• – – |
2022-05-27 |
4 |
D |
$70.81 |
$9,984 |
D/D |
(141) |
7,614 |
|
- |
|
| Vosseller Leigh |
EVP & CHIEF FINANCIAL OFFICER |
• – – |
2022-05-27 |
4 |
OE |
$0.00 |
$0 |
D/D |
406 |
7,755 |
|
- |
|
| Berger David B |
EVP & Chief Operating Officer |
• – – |
2022-05-27 |
4 |
D |
$70.81 |
$14,304 |
D/D |
(202) |
5,554 |
|
- |
|
| Berger David B |
EVP & Chief Operating Officer |
• – – |
2022-05-27 |
4 |
OE |
$0.00 |
$0 |
D/D |
406 |
5,756 |
|
- |
|
| Roeder Douglas A |
Director |
– • – |
2022-05-18 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,205 |
2,205 |
|
- |
|
| Allen Dick |
Director |
– • – |
2022-05-18 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,205 |
2,205 |
|
- |
|
| Howell Peyton R |
Director |
– • – |
2022-05-18 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,653 |
4,601 |
|
- |
|
| Blickenstaff Kim D |
Director |
– • – |
2022-05-18 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,205 |
10,657 |
|
- |
|
| Robertson Rebecca B |
Director |
– • – |
2022-05-18 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,205 |
2,205 |
|
- |
|
| Sodhi Rajwant |
Director |
– • – |
2022-05-18 |
4 |
OE |
$0.00 |
$0 |
D/D |
735 |
1,804 |
|
- |
|
| Twomey Christopher J |
Director |
– • – |
2022-05-18 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,205 |
4,097 |
|
- |
|
| Mcgroddy-Goetz Kathleen |
Director |
– • – |
2022-05-18 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,021 |
2,835 |
|
- |
|
| Blickenstaff Kim D |
Director |
– • – |
2022-05-17 |
4 |
S |
$92.91 |
$999,897 |
I/I |
(10,762) |
205,190 |
|
38% |
|
| Blickenstaff Kim D |
Director |
– • – |
2022-05-17 |
4 |
OE |
$73.73 |
$999,872 |
I/I |
13,562 |
215,952 |
|
- |
|
| Blickenstaff Kim D |
Director |
– • – |
2022-05-17 |
4 |
OE |
$9.00 |
$59,040 |
D/D |
6,560 |
8,452 |
|
- |
|
| Hansen Brian B |
EVP & CHIEF COMMERCIAL OFFICER |
• – – |
2022-05-16 |
4 |
A |
$61.17 |
$18,718 |
D/D |
306 |
7,552 |
|
- |
|
| Hansen Brian B |
EVP & CHIEF COMMERCIAL OFFICER |
• – – |
2022-05-16 |
4 |
D |
$73.85 |
$15,582 |
D/D |
(211) |
7,246 |
|
- |
|
| Hansen Brian B |
EVP & CHIEF COMMERCIAL OFFICER |
• – – |
2022-05-16 |
4 |
OE |
$0.00 |
$0 |
D/D |
650 |
7,457 |
|
- |
|
| Vosseller Leigh |
EVP & CHIEF FINANCIAL OFFICER |
• – – |
2022-05-16 |
4 |
A |
$61.17 |
$18,718 |
D/D |
306 |
7,349 |
|
- |
|
845 Records found
|
|
Page 13 of 34 |
|
|
2.05 (4.13%) 
